Yohann Schmitt

3.1k total citations
12 papers, 339 citations indexed

About

Yohann Schmitt is a scholar working on Genetics, Molecular Biology and Cancer Research. According to data from OpenAlex, Yohann Schmitt has authored 12 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 5 papers in Molecular Biology and 4 papers in Cancer Research. Recurrent topics in Yohann Schmitt's work include Glioma Diagnosis and Treatment (8 papers), Radiomics and Machine Learning in Medical Imaging (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Yohann Schmitt is often cited by papers focused on Glioma Diagnosis and Treatment (8 papers), Radiomics and Machine Learning in Medical Imaging (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Yohann Schmitt collaborates with scholars based in France, United States and Italy. Yohann Schmitt's co-authors include Marc Sanson, Karima Mokhtari, Anna Luisa Di Stefano, Hans Sommer, Veerle Moons, Mark Stetter, Marine Giry, Agustí Alentorn, Marianne Labussière and Franck Bielle and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and Neurology.

In The Last Decade

Yohann Schmitt

12 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yohann Schmitt France 8 178 112 91 72 66 12 339
Anna Antenucci Italy 11 88 0.5× 23 0.2× 226 2.5× 222 3.1× 24 0.4× 18 446
Mari Kirishima Japan 10 96 0.5× 39 0.3× 78 0.9× 57 0.8× 16 0.2× 34 272
Francesco Autore Italy 11 169 0.9× 34 0.3× 49 0.5× 19 0.3× 16 0.2× 54 316
Gregory Schneiter Switzerland 6 58 0.3× 30 0.3× 78 0.9× 32 0.4× 95 1.4× 6 474
Caterina Matteucci Italy 15 117 0.7× 39 0.3× 219 2.4× 40 0.6× 46 0.7× 49 604
O. Yu. Leplina Russia 12 111 0.6× 35 0.3× 76 0.8× 15 0.2× 21 0.3× 56 361
Kaleigh Fetcko United States 6 86 0.5× 31 0.3× 47 0.5× 21 0.3× 6 0.1× 9 273
G-X Yang United States 9 17 0.1× 128 1.1× 56 0.6× 52 0.7× 139 2.1× 10 317
Gregorio Barilà Italy 16 207 1.2× 26 0.2× 109 1.2× 13 0.2× 12 0.2× 38 509

Countries citing papers authored by Yohann Schmitt

Since Specialization
Citations

This map shows the geographic impact of Yohann Schmitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yohann Schmitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yohann Schmitt more than expected).

Fields of papers citing papers by Yohann Schmitt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yohann Schmitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yohann Schmitt. The network helps show where Yohann Schmitt may publish in the future.

Co-authorship network of co-authors of Yohann Schmitt

This figure shows the co-authorship network connecting the top 25 collaborators of Yohann Schmitt. A scholar is included among the top collaborators of Yohann Schmitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yohann Schmitt. Yohann Schmitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Lombardi, Emilia Puig, Bénédicte Hoareau‐Coudert, Yohann Schmitt, et al.. (2023). A neomorphic mutation in the interferon activation domain of IRF4 causes a dominant primary immunodeficiency. The Journal of Experimental Medicine. 220(6). 7 indexed citations
2.
Pïcca, Alberto, Anna Luisa Di Stefano, Julien Savatovsky, et al.. (2023). CTNI-33. TARGET TRIAL: A PHASE I/II OPEN-LABEL MULTICENTER STUDY TO ASSESS SAFETY, TOLERABILITY, AND CLINICAL EFFICACY OF AZD4547 IN PATIENTS WITH RELAPSED/REFRACTORY FGFR FUSION POSITIVE GLIOMA. Neuro-Oncology. 25(Supplement_5). v81–v81. 2 indexed citations
3.
Berzero, Giulia, Anna Luisa Di Stefano, Susanna Ronchi, et al.. (2020). IDH-wildtype lower-grade diffuse gliomas: the importance of histological grade and molecular assessment for prognostic stratification. Neuro-Oncology. 23(6). 955–966. 82 indexed citations
4.
Pïcca, Alberto, Franck Bielle, François Ducray, et al.. (2019). OS9.3 Clinical, molecular and radiomic profile of gliomas with FGFR3-TACC3 fusion. Neuro-Oncology. 21(Supplement_3). iii18–iii19. 1 indexed citations
5.
Pïcca, Alberto, Giulia Berzero, Agustí Alentorn, et al.. (2018). Actionable targets involving FGF receptors in gliomas: Molecular specificities, spatial distribution, clinical outcome and radiological phenotype.. Journal of Clinical Oncology. 36(15_suppl). 2005–2005. 3 indexed citations
6.
Pïcca, Alberto, Giulia Berzero, Franck Bielle, et al.. (2018). FGFR1 actionable mutations, molecular specificities, and outcome of adult midline gliomas. Neurology. 90(23). 40 indexed citations
7.
Bielle, Franck, Anna Luisa Di Stefano, David Meyronet, et al.. (2017). Diffuse gliomas with FGFR3‐TACC3 fusion have characteristic histopathological and molecular features. Brain Pathology. 28(5). 674–683. 40 indexed citations
8.
Labussière, Marianne, Amithys Rahimian, Marine Giry, et al.. (2016). Chromosome 17p Homodisomy Is Associated With Better Outcome in 1p19q Non-Codeleted and IDH-Mutated Gliomas. The Oncologist. 21(9). 1131–1135. 7 indexed citations
9.
Tabouret, Émeline, Marianne Labussière, Agustí Alentorn, et al.. (2015). LRP1B deletion is associated with poor outcome for glioblastoma patients. Journal of the Neurological Sciences. 358(1-2). 440–443. 37 indexed citations
10.
Rahimian, Amithys, Marine Giry, Andrea Sechi, et al.. (2015). TERT promoter mutations and rs2853669 polymorphism: prognostic impact and interactions with common alterations in glioblastomas. Journal of Neuro-Oncology. 126(3). 441–446. 33 indexed citations
11.
Moons, Veerle, et al.. (2004). Evaluation of sensitivity for wild type and mutant forms of hepatitis B surface antigen by four commercial HBsAg assays.. PubMed. 50(3-4). 159–62. 67 indexed citations
12.
Toulon, Pierre, et al.. (2000). Screening for abnormalities of the protein C anticoagulant pathway using the ProC Global assay. Results of a European multicenter evaluation. Blood Coagulation & Fibrinolysis. 11(5). 447–454. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Antenucci Breakdown of academic impact, for papers by Mari Kirishima Breakdown of academic impact, for papers by Francesco Autore Breakdown of academic impact, for papers by Gregory Schneiter Breakdown of academic impact, for papers by Caterina Matteucci Breakdown of academic impact, for papers by O. Yu. Leplina Breakdown of academic impact, for papers by Kaleigh Fetcko Breakdown of academic impact, for papers by G-X Yang Breakdown of academic impact, for papers by Gregorio Barilà
Rankless by CCL
2026